Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danny M Cohn

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Clinical Reviews in Allergy & Immunology|March 7, 2025
Hereditary Angioedema with Normal C1 Inhibitor: an Updated International Consensus Paper on Diagnosis, Pathophysiology, and TreatmentBruce L Zuraw, Konrad Bork, Laurence Bouillet, et al.
The Journal of Allergy and Clinical Immunology. Global|April 25, 2025
Global frequency, diagnosis, and treatment of hereditary angioedema with normal C1 inhibitorMarkus Magerl, Marc A Riedl, Luisa Karla Arruda, et al.
Journal of Critical Care|August 3, 2024
Antisense therapy to block the Kallikrein-kinin pathway in COVID-19: The ASKCOV randomized controlled trialFernando G Zampieri, Glauco Adrieno Westphal, Maria Adelaide Dos Santos, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 31, 2025
Long-term Safety and Effectiveness of Sebetralstat: Interim Analysis of KONFIDENT-S Open-label ExtensionHenriette Farkas, John Anderson, Laurence Bouillet, et al.
The Lancet. Haematology|March 22, 2026
Oral deucrictibant for on-demand treatment of hereditary angioedema attacks (RAPIDe-1): a randomised, double-blind, placebo-controlled, phase 2 trialMarcus Maurer, Marcin Stobiecki, Anna Valerieva, et al.
The World Allergy Organization Journal|June 19, 2026
Sebetralstat for on-demand treatment of hereditary angioedema: A pooled analysis of placebo-controlled clinical trialsEmel Aygören-Pürsün, Danny M Cohn, Nancy Agmon-Levin, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 12, 2024
A Core Outcome Set for Efficacy of Acute Treatment of Hereditary AngioedemaRemy S Petersen, Lauré M Fijen, Christian Apfelbacher, et al.
Allergy|January 10, 2022
The international WAO/EAACI guideline for the management of hereditary angioedema-The 2021 revision and updateMarcus Maurer, Markus Magerl, Stephen Betschel, et al.
The World Allergy Organization Journal|May 2, 2022
The international WAO/EAACI guideline for the management of hereditary angioedema - The 2021 revision and updateMarcus Maurer, Markus Magerl, Stephen Betschel, et al.
The Journal of Allergy and Clinical Immunology|April 26, 2024
Definition, acronyms, nomenclature, and classification of angioedema (DANCE): AAAAI, ACAAI, ACARE, and APAAACI DANCE consensusAvner Reshef, Thomas Buttgereit, Stephen D Betschel, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Clinical Reviews in Allergy & Immunology|March 7, 2025
Hereditary Angioedema with Normal C1 Inhibitor: an Updated International Consensus Paper on Diagnosis, Pathophysiology, and TreatmentBruce L Zuraw, Konrad Bork, Laurence Bouillet, et al.
The Journal of Allergy and Clinical Immunology. Global|April 25, 2025
Global frequency, diagnosis, and treatment of hereditary angioedema with normal C1 inhibitorMarkus Magerl, Marc A Riedl, Luisa Karla Arruda, et al.
Journal of Critical Care|August 3, 2024
Antisense therapy to block the Kallikrein-kinin pathway in COVID-19: The ASKCOV randomized controlled trialFernando G Zampieri, Glauco Adrieno Westphal, Maria Adelaide Dos Santos, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 31, 2025
Long-term Safety and Effectiveness of Sebetralstat: Interim Analysis of KONFIDENT-S Open-label ExtensionHenriette Farkas, John Anderson, Laurence Bouillet, et al.
The Lancet. Haematology|March 22, 2026
Oral deucrictibant for on-demand treatment of hereditary angioedema attacks (RAPIDe-1): a randomised, double-blind, placebo-controlled, phase 2 trialMarcus Maurer, Marcin Stobiecki, Anna Valerieva, et al.
The World Allergy Organization Journal|June 19, 2026
Sebetralstat for on-demand treatment of hereditary angioedema: A pooled analysis of placebo-controlled clinical trialsEmel Aygören-Pürsün, Danny M Cohn, Nancy Agmon-Levin, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 12, 2024
A Core Outcome Set for Efficacy of Acute Treatment of Hereditary AngioedemaRemy S Petersen, Lauré M Fijen, Christian Apfelbacher, et al.
Allergy|January 10, 2022
The international WAO/EAACI guideline for the management of hereditary angioedema-The 2021 revision and updateMarcus Maurer, Markus Magerl, Stephen Betschel, et al.
The World Allergy Organization Journal|May 2, 2022
The international WAO/EAACI guideline for the management of hereditary angioedema - The 2021 revision and updateMarcus Maurer, Markus Magerl, Stephen Betschel, et al.
The Journal of Allergy and Clinical Immunology|April 26, 2024
Definition, acronyms, nomenclature, and classification of angioedema (DANCE): AAAAI, ACAAI, ACARE, and APAAACI DANCE consensusAvner Reshef, Thomas Buttgereit, Stephen D Betschel, et al.
Pageof 9